|
[1]
|
Chen, W., Zheng, R., Baade, P.D., et al. (2016) Cancer Statistics in China, 2015. CA: A Cancer Journal for Clinicians, 66, 115-132. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Allemani, C., Matsuda, T., Di Carlo, V., et al. (2018) Global Surveillance of Trends in Cancer Survival 2000-14 (CONCORD-3): Analysis of Individual Records for 37,513,025 Patients Diagnosed with One of 18 Cancers from 322 Population-Based Registries in 71 Countries. Lancet, 391, 1023-1075.
[Google Scholar] [CrossRef]
|
|
[3]
|
Guo, X.Y., Wang, P., Du, Q.G., et al. (2015) Paclitaxel and Gemcitabine Combinational Drug-Loaded Mucoadhesive Delivery System in the Treatment of Colon Cancers. Drug Research (Stuttg), 65, 199-204.
|
|
[4]
|
Xiong, M., Lei, Q., You, X., et al. (2017) Mannosylated Liposomes Improve Therapeutic Effects of Paclitaxel in Colon Cancer Models. Journal of Microencapsulation, 34, 513-521. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Zhao, B.G., Vasilakos, J.P., Tross, D., et al. (2014) Combination Therapy Targeting Toll Like Receptors 7, 8 and 9 Eliminates Large Established Tumors. Journal for ImmunoTherapy of Cancer, 2, 12.
[Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Soriano, A.F., Helfrich, B., Chan, D.C., et al. (1999) Synergistic Effects of New Chemopreventive Agents and Conventional Cytotoxic Agents against Human Lung Cancer Cell Lines. Cancer Research, 59, 6178-6184.
|
|
[7]
|
Xu, M., Li, M., Yang, J., et al. (2014) Adenovirus-Mediated Interleukin-24 Enhances the Inhibitory Effect of Paclitaxel on the Growth of Lung Cancer A549 Cells. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, 30, 1150-1153.
|
|
[8]
|
Tanimukai, H., Kanayama, D., Omi, T., et al. (2013) Paclitaxel Induces Neurotoxicity through Endoplasmic Reticulum Stress. Biochemical and Bi-ophysical Research Communications, 437, 151-155.
[Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Mullins, S.R., Vogel, K., Vasilakos, J.P., et al. (2017) Intratumoral Immuno-therapy with TLR7/8 Agonist MEDI9197 Modulates the Tumor Microenvironment and Holds Potential for Combination with Immune Checkpoint Inhibitors. Cancer Research, 77, 4697. [Google Scholar] [CrossRef]
|
|
[10]
|
Porichi, O., Nikolaidou, M.E., Apostolaki, A., et al. (2009) BCL-2, BAX and P53 Expression Profiles in Endometrial Carcinoma as Studied by Real-Time PCR and Immunohistochemistry. Anticancer Research, 29, 3977-3982.
|